Vanguard Group’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.5M | Sell |
|
|||||
|
2025
Q1 | $31.7M | Sell |
|
|||||
|
2024
Q4 | $61.9M | Buy |
|
|||||
|
2024
Q3 | $102M | Buy |
|
|||||
|
2024
Q2 | $76.3M | Sell |
|
|||||
|
2024
Q1 | $98.1M | Buy |
|
|||||
|
2023
Q4 | $117M | Buy |
|
|||||
|
2023
Q3 | $88.7M | Buy |
|
|||||
|
2023
Q2 | $132M | Buy |
|
|||||
|
2023
Q1 | $173M | Buy |
|
|||||
|
2022
Q4 | $155M | Buy |
|
|||||
|
2022
Q3 | $187M | Buy |
|
|||||
|
2022
Q2 | $119M | Buy |
|
|||||
|
2022
Q1 | $186M | Buy |
|
|||||
|
2021
Q4 | $190M | Buy |
|
|||||
|
2021
Q3 | $154M | Buy |
|
|||||
|
2021
Q2 | $157M | Buy |
|
|||||
|
2021
Q1 | $140M | Buy |
|
|||||
|
2020
Q4 | $71.5M | Buy |
|
|||||
|
2020
Q3 | $69.5M | Buy |
|